Viking Therapeutics Faces Investor Setback as Obesity Pill Trial Highlights ChallengesBusiness PenAugust 20, 2025 August 20, 2025 [stock_market_widget type=”card” template=”basic2″ assets=”VKTX” realtime=”true” api=”yahoo-finance”] Viking Therapeutics (NASDAQ: VKTX) saw its stock plunge sharply following the release of Phase 2 trial results for its...